The Food and Drug Administration has turned away a proposed nasal spray from Milestone Pharmaceuticals to treat a type of irregular heartbeat over concerns about how the drug is manufactured.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback